Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria
Clinical trial NCT03791918 · WITHDRAWN
Trial details
- NCT number
- NCT03791918
- Sponsor
- Sun Yat-sen University
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2022-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.